Výsledky vyhledávání - "Adrian S. Ishkanian"

Supplementary Figure 2 from NKX3.1 Haploinsufficiency Is Prognostic for Prostate Cancer Relapse following Surgery or Image-Guided Radiotherapy

Autor: Robert G. Bristow, Theo van der Kwast, Igor Jurisica, Omer Ahmed, Alice Meng, Varune Rohan Ramnarine, Jenna Sykes, Melania Pintilie, Jeremy A. Squire, Wan L. Lam, Chad A. Malloff, Cherry L. Have, John Thoms, Michael Milosevic, Adrian S. Ishkanian, Gaetano Zafarana, Jennifer A. Locke

PDF file - 41K, Percentage genome alteration (PGA) levels are displayed for patient biopsies categorized as per their NKX3.1/T-category status (a), NKX3.1/PSA status (b), NKX3.1/Gleason-score status (c), NKX3.1/c-MYC/T-category status (d) and NKX3.1/

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a35d84b0dd25aadc18202def37b13754
https://doi.org/10.1158/1078-0432.22447703

Zobrazit plný text záznamu

Supplementary Figure Legends 1-2, Tables 1-6 from NKX3.1 Haploinsufficiency Is Prognostic for Prostate Cancer Relapse following Surgery or Image-Guided Radiotherapy

Supplementary Figure Legends 1-2, Tables 1-6 from NKX3.1 Haploinsufficiency Is Prognostic for Prostate Cancer Relapse following Surgery or Image-Guided Radiotherapy

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c741d5204d4fbb34561b1cd3346642ee
https://doi.org/10.1158/1078-0432.22447700.v1

Zobrazit plný text záznamu

Data from NKX3.1 Haploinsufficiency Is Prognostic for Prostate Cancer Relapse following Surgery or Image-Guided Radiotherapy

Background: Despite the use of prostate specific antigen (PSA), Gleason-score, and T-category as prognostic factors, up to 40% of patients with intermediate-risk prostate cancer will fail radical prostatectomy or precision image-guided radiotherapy (

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::51550384b0bae2ce07e6be8270ed19cd
https://doi.org/10.1158/1078-0432.c.6521168.v1

Zobrazit plný text záznamu

High-resolution array CGH identifies novel regions of genomic alteration in intermediate-risk prostate cancer

Autor: Adrian S, Ishkanian, Chad A, Mallof, James, Ho, Alice, Meng, Monique, Albert, Amena, Syed, Theodorus, van der Kwast, Michael, Milosevic, Maisa, Yoshimoto, Jeremy A, Squire, Wan L, Lam, Robert G, Bristow

Publikováno v: The Prostate. 69(10)

Approximately one-third of prostate cancer patients present with intermediate risk disease. Interestingly, while this risk group is clinically well defined, it demonstrates the most significant heterogeneity in PSA-based biochemical outcome. Further,

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::4a500eade49b37765f5b24a734dc7bdc
https://pubmed.ncbi.nlm.nih.gov/19350549

Zobrazit plný text záznamu

Methods for high throughput validation of amplified fragment pools of BAC DNA for constructing high resolution CGH arrays

Autor: Spencer K Watson, Wan L. Lam, Chad A Malloff, Adrian S Ishkanian, R. J. deLeeuw

Publikováno v: BMC Genomics
BMC Genomics, Vol 5, Iss 1, p 6 (2004)

Background The recent development of array based comparative genomic hybridization (CGH) technology provides improved resolution for detection of genomic DNA copy number alterations. In array CGH, generating spotting solution is a multi-step process

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1bcd817a2cc2a69cd891066526c319ca
http://europepmc.org/articles/PMC324397

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání